相关实验视频
Updated: Jan 16, 2026

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
9.3K
药物反应与埃索诺菲利亚和系统性症状二次到乙胺醇
Sonja Kapadia1, Alexa Mackinnon1, Brigitte Burcescu2
1Warren Alpert Medical School of Brown University.
Journal of Brown hospital medicine
|October 6, 2025
概括
药物反应与埃索诺菲利亚和全身症状 (DRESS) 是一种严重的免疫反应. 这一案例突出了诊断患有Mycobacterium marinum感染的患者因乙醇引起的DRESS的挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 传染性疾病 传染性疾病
背景情况:
- 药物反应与埃索诺菲利亚和全身症状 (DRESS) 是一种严重的,T细胞介导的药物过敏症.
- DRESS综合征可能会导致严重的末端器官损伤,并与特定的药物触发因素有关.
- 菌根菌感染可以出现皮肤病变和细胞炎,需要抗生素治疗.
研究的目的:
- 报告一个罕见的DRESS综合征病例,可能是由乙醇激发的.
- 描述DRESS在患有并发M. marinum感染的患者中所面临的诊断和管理挑战.
- 为了突出DRESS在M. marinum细胞炎的背景下独特的呈现.
主要方法:
- 一个65岁的女性患者的病例报告.
- 对临床表现,实验室发现和治疗过程的审查.
- 药物暴露与症状发作和DRESS诊断标准的相关性.
主要成果:
- 患者出现了皮疹,发烧和腹部疼痛.
- 同时诊断M. marinum细胞炎,需要除菌和抗生素.
- 乙墨托尔被确定为DRESS最可能的致病原体,这是与M. marinum.的新兴关联.
- 由于症状重叠,在区分DRESS和M. marinum感染方面存在挑战.
结论:
- 诊断DRESS综合征可能具有挑战性,特别是在同时存在的感染的情况下.
- 即使在M. marinum感染的情况下,Ethambutol也应该被视为潜在的DRESS触发剂.
- 早期识别和管理对于复杂的DRESS案件的良好结果至关重要.
相关概念视频
Allergic Reactions
32.0K
Overview
32.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Cross-reactivity
32.8K
Overview
32.8K
Antiasthma Drugs: Methylxanthines
1.6K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.6K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K

